Attenua

Developer of non-narcotic medicines for a chronic cough

placeSan Francisco, California, United States calendar_todayFounded 2015 language attenua.com

Innovation

6 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace dormant. Cited 292 times.

YearFilings
20161
20175
20182
20191

Investor mix

4 investors on record; lead investors include Omega Funds.

Investor typeCountShare
Venture capital375%
Other / undisclosed125%
Coming soon